ACR-ASNR Practice Parameter for Brain PET/CT Imaging Dementia

Kirk A. Frey, Martin A. Lodge, Carolyn Cidis Meltzer, Patrick J. Peller, Terence Z. Wong, Christopher P. Hess, Jeffrey R. Petrella, Haris I. Sair, Rathan M. Subramaniam

Research output: Contribution to journalArticlepeer-review

10 Scopus citations


This practice parameter is for both FDG and amyloid brain PET or PET/computed tomography (CT) for patients with cognitive decline, and has been developed collaboratively by the American College of Radiology (ACR) and the American Society for Neuroradiology (ASNR). It is estimated that the number of people with dementia, 36.5 million worldwide in 2010, will increase to 65.7 million in 2030 and to 115 million in 2050. Four primary neurodegenerative etiologies of dementia have been defined: Alzheimer disease (AD), vascular dementia, frontotemporal dementia (FTD), and dementia with Lewy bodies (DLB). Alzheimer disease is the most common form of dementia, accounting for approximately 60%-80% of all cases. Indications for FDG and amyloid brain PET and qualifications for personnel are discussed in this practice parameter.

Original languageEnglish (US)
Pages (from-to)118-125
Number of pages8
JournalClinical nuclear medicine
Issue number2
StatePublished - Feb 1 2016


  • Alzheimer disease
  • Brain PET/CT
  • Brain imaging
  • FTD
  • PET/CT
  • amyloid PET
  • dementia
  • frontotemporal dementia
  • memory
  • vascular dementia

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging


Dive into the research topics of 'ACR-ASNR Practice Parameter for Brain PET/CT Imaging Dementia'. Together they form a unique fingerprint.

Cite this